BiOfeedback, Online for Sibilant Treatment

计划入组 6 人 · 首次发布于 2025 年 6 月 27 日

MICROBIOTA AND BLADDER CANCER

计划入组 95 人 · 首次发布于 2025 年 7 月 23 日

Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer

计划入组 2 人 · 首次发布于 2010 年 7 月 2 日

PI3K/Akt/mTOR inhibitors (Endo/Jubilant Biosys)

PAD4 inhibitors (Jubilant Therapeutics)

EGFR L858R/T790M inhibitors (Jubilant Lifesciences)

JUBILANT PHARMOVA LIMITED

India

Jubilant DraxImage Inc.

United States

Jubilant Draximage Inc

Canada

Jubilant Biosys Strengthens Leadership with Somesh Sharma as COO of Drug Discovery Services

Jubilant Biosys Convenes 2nd EDGE Innovation Forum, Uniting Biotech Founders, Investors, and Pharma Leaders to Accelerate Next-Generation Therapies

Jubilant Pharmova Secures USFDA Tentative Approval for Pantoprazole Oral Suspension, Eyes 2026 Launch